The relationship between Lin28 and the chemotherapy response of gastric cancer

OncoTargets and Therapy

Volumn 6, Issue , 2013, Pages 1341-1345

  Teng, Rong Yue ^a   Zhou, Ji Chun ^a   Jiang, Zi Nong ^a   Xu, Chao Yang ^b   Li, Zi Duo ^a   Wang, Qing Chuan ^a   Xu, Chen Pu ^a   Guo, Ju Feng ^a   Shen, Jian Guo ^a   Wang, Lin Bo ^a,c  

^a ZHEJIANG UNIVERSITY   (China)

^b Shaoxing People's Hospital   (China)

^c Biomedical Research Center Key Laboratory of Biotherapy of Zhejiang Province   (China)

Author keywords

Immunohistochemistry; Neoadjuvant chemotherapy; Pathologic tumor response; Stem cell biomarker

Indexed keywords

LIN28; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; ENDOSCOPIC BIOPSY; FEMALE; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PREDICTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; STOMACH BIOPSY; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR REGRESSION;

EID: 84884715110     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S45705     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Napieralski R, Ott K, Kremer M, Specht K, Vogelsang H, Becker K, Müller M, Lordick F, et al. Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients. Clin Cancer Res. 2005;11:3025-3031.
3. Hirakawa M, Sato Y, Ohnuma H, Takayama T, Sagawa T, Nobuoka T, Harada K et al. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker. Cancer Chemother Pharmacol. 2013;71:789-797.
4. Moss EG, Lee RC, Ambros V. The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell. 1997;88(5):637-646.
5. Yang DH, Moss EG. Temporally regulated expression of Lin-28in diverse tissues of the developing mouse. Gene Expr Patterns. 2003;3(6): 719-726.
6. Viswanathan SR, Powers JT, Einhorn W, etal. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. 2009;41(7):843-848.
7. Guo Y, Chen Y, Ito H, etal. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene. 2006;384:51-61.
8. Xu C, Shen J, Xie S, Jiang Z, Huang L, Wang L. Positive expression of Lin28 is correlated with poor survival in gastric carcinoma. Med Oncol. 2013;30(1):382.
9. Oh JS, Kim JJ, Byun JY, Kim IA. Lin28-let7modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys. 2010;76(1):5-8.
10. Wang LB, Teng RY, Jiang ZN, etal. Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer. J Surg Oncol. 2012;105(3):293-296.
11. Becker K, Mueller JD, Schulmacher C, etal. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer. 2003;98(7):1521-1530.
12. Liu K, Qian T, Tang L, Wang J, Yang H, Ren J. Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer. World J Surg Oncol. 2012;10:225.
13. Teo K, Gemmell L, Mukherjee R, Traynor P, Edwards J. Bad expression influences time to androgen escape in prostate cancer. BJU Int. 2007;100(3):691-696.
14. Wagner AD, Unverzagt S, Grothe W, etal. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2010;(3):CD004064.
15. Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. World J Gastroenterol. 2010;16(44): 5621-5628.
16. Saigusa S, Tanaka K, Toiyama Y, etal. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy. Oncol Rep. 2012;28(3):855-861.
17. Lv K, Liu L, Wang L, etal. Lin28mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells. PLoS One. 2012;7(7):e40008.
18. Heo I, Joo C, Kim YK, etal. TUT4in concert with Lin28suppresses microRNA biogenesis through pre-microRNA uridylation. Cell. 2009;138(4):696-708.
19. Yang X, Lin X, Zhong X, Kaur S, Li N, Liang S, Lassus H et al. Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells. Cancer Res. 201015;70(22):9463-9472.
20. Viswanathan SR, Daley GQ. Lin28: A microRNA regulator with a macro role. Cell. 2010;140(4):445-449.
21. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7in cell differentiation and cancer. Endocr Relat Cancer. 2010;17(1):F19-F36.
22. Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease? Trends Cell Biol. 2012;22(9):474-482.